Pune, India — 02/14/2018 — Global Injectable Drug Delivery Market is expected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Injectable drug delivery market has the largest market segment in Drug delivery market.
Click Here For Free Sample Report @: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-injectable-drug-delivery-market
Some of the Top Key Players:
Baxter International, Inc., Becton, Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, and Teva Pharmaceuticals Industries Ltd.
Becton, Dickinson and Company:
Founded in 1897 as Becton, Dickinson and Company and head quartered in New Jersey, U.S. is focused on developing, manufacturing and sales of medical supplies, devices, laboratory equipment and diagnostic products. The company operates through two business segments: BD Medical and BD Life Sciences.
To Know More About in short click here: https://youtu.be/eSCDbJ9zmsU
Incorporated in June 1942 and headquartered in New York, U.S. Pfizer Inc., is engaged in discovering, developing and, manufacturing of healthcare products. Pfizer Inc., operates through two segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The Company's IH segment concentrates on creating and commercializing immunizations and prescriptions that enhance patients' lives, and in addition products for the end user health care.
The major factors driving the growth of this market are the increasing use of biologics, rising prevalence of chronic diseases, increasing occurrence of needle stick injuries, and the benefits of injections (convenience, ease of use, and reduced pain). These factors increase the demand for devices such as safety syringes, prefilled syringes, and auto-disabled syringes. On the other hand, safety concerns regarding the use of injectable, increased risk of blood-borne infections due to injectable and presence of other drug delivery methods (such as oral and transdermal) may hinder the growth of the market.
Company Share Study:
The report also includes company's share analysis for the major companies operating in this market by major regions as North America, Europe and Asia Pacific. The details of mergers and acquisitions, product launches, expansions, and product life cycle matrix are also a part of this report.
The Injectable drug delivery market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
Have Any Query? Ask Our Expert: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-injectable-drug-delivery-market
Other Market Insights:
North America injectable drug delivery market is expected to reach USD 354.5 billion by 2024 from USD 154.0 billion in 2016, at a CAGR of 11.0% in the forecast period 2017 to 2024.
About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Email: [email protected]
Investor: [email protected]
Visit Blog http://databridgemarketresearch.com/blog/
Latest posts by Jasmine Petters (see all)
- Deluxe Organic Milk aus China auf der BioFach 2018 - February 18, 2018
- Hilary Musser Collection Achieves Excellent Results at Kaminski Auctions - February 18, 2018
- AIEP Host Families Celebrates Chinese New Year - February 18, 2018